NOSCM-071924 - Dr Edgardo S. Santos with Dr Ahmed Zakari Interview
Update: 2025-08-25
Description
Interviews with Summit Director Edgardo S. Santos Castillero, MD, FACP, FASCO
NOSCM 2024 | New Orleans Summer Cancer Meeting
NOSCM-071924 - Dr E.dgardo S. Santos with Dr Ahmed Zakari Interview
Drs. Santos and Zakari highlighted that tumor-informed ctDNA testing in oligometastatic colorectal cancer can detect minimal residual disease—helping identify patients unlikely to benefit from adjuvant chemotherapy—with repeat assays raising sensitivity to 80–85%. They also noted ASCO’s recent preference for fluorouracil in upper GI adenocarcinomas and underscored ctDNA’s prognostic value in the GALAXY trial.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
